This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer
Evidence-Based Benefits
Cardiovascular protection — a 2013 meta-analysis of 13 controlled trials (n=3,629) found L-carnitine reduced all-cause mortality by 27% in acute MI patients (DiNicolantonio et al., Mayo Clinic Proceedings)
Exercise recovery — L-carnitine L-tartrate at 2 g/day reduced markers of muscle damage and improved recovery in resistance-trained men (Spiering et al., 2007)
Peripheral artery disease — L-carnitine and propionyl-L-carnitine improve walking distance in intermittent claudication (Cochrane review, 2013)
Male fertility — a meta-analysis found L-carnitine supplementation improved sperm motility and morphology (Lafuente et al., 2013)
Type 2 diabetes — a 2016 meta-analysis found carnitine supplementation improved fasting glucose and HOMA-IR in diabetic patients (Vidal-Casariego et al.)
What the Research Says
L-Carnitine is a nutrient involved in energy metabolism and has been extensively studied for its potential health benefits across various conditions. In cardiovascular medicine, DiNicolantonio et al. (2013) conducted a systematic review and meta-analysis that found L-carnitine supplementation significantly reduced mortality post-myocardial infarction (MI), with a 27% reduction in risk. This underscores its strong evidence for supporting cardiovascular health.
In the context of metabolic disorders, Mirrafiei et al. (2024) performed a systematic review and meta-analysis of 21 randomized controlled trials involving 2041 participants with type 2 diabetes. The study demonstrated that L-carnitine supplementation significantly improved cardiometabolic markers, including reductions in BMI, HbA1c, LDL cholesterol, triglycerides, total cholesterol, and fasting plasma glucose. Similarly, Li et al. (2023) reviewed 15 trials with 12,221 adults and reported that L-carnitine supplementation improved glucolipid metabolism by reducing fasting blood glucose, insulin resistance, triglycerides, total cholesterol, LDL cholesterol, and ALT levels.
Despite these benefits, caution is warranted due to findings from Koeth et al. (2013), who linked high doses of carnitine to gut-bacteria-mediated production of trimethylamine N-oxide (TMAO), a compound associated with an increased risk of atherosclerosis. This finding has sparked debate regarding the long-term safety of chronic high-dose L-carnitine supplementation.
In sports nutrition, while L-carnitine L-tartrate shows promise for recovery, claims about fat-burning in healthy adults are overstated (Spiering et al., 2007). Additionally, studies on other conditions such as septic shock and polycystic ovary syndrome (PCOS) have yielded mixed results. For instance, Guedes et al. (2022) found no significant effect of L-carnitine supplementation on 28-day mortality in septic shock patients, while Mohd Shukri et al. (2022) reported moderate evidence that L-carnitine improved lipid profiles and fasting glucose levels in women with PCOS.
Overall, L-Carnitine demonstrates strong evidence for cardiovascular benefits and metabolic support, particularly in individuals with type 2 diabetes, but its use should be tailored to individual needs and considerations of
Meta-analysisDiNicolantonio JJ, Lavie CJ, Fares H, et al. (2013). L-Carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis. Mayo Clinic Proceedings. DOIPubMed
RCTSpiering BA, Kraemer WJ, Vingren JL, et al. (2007). Responses of criterion variables to different supplemental doses of L-carnitine L-tartrate. Journal of Strength and Conditioning Research. DOIPubMed
Ma X, Yang Y, Liu S, Cui Y, et al. (2025). Meta-analysis of the efficacy and safety of L-carnitine and N-acetylcysteine monotherapy for male idiopathic infertility.. Revista internacional de andrologia. DOIPubMed
Meta-analysisHamedi-Kalajahi F, Zarezadeh M, Malekahmadi M, Jamilian P, et al. (2025). The Effect of the L-Carnitine Supplementation on Obesity Indices: An Umbrella Meta-Analysis.. International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition. DOIPubMed
Meta-analysisMirrafiei A, Jayedi A, Shab-Bidar S (2024). The Effects of L-Carnitine Supplementation on Weight Loss, Glycemic Control, and Cardiovascular Risk Factors in Patients With Type 2 Diabetes: A Systematic Review and Dose-response Meta-Analysis of Randomized Controlled Trials.. Clinical therapeutics. DOIPubMed
Li Y, Xie Y, Qiu C, Yu B, et al. (2023). Effects of L-carnitine supplementation on glucolipid metabolism: a systematic review and meta-analysis.. Food & function. DOIPubMed
Meta-analysisRastgoo S, Fateh ST, Nikbaf-Shandiz M, Rasaei N, et al. (2023). The effects of L-carnitine supplementation on inflammatory and anti-inflammatory markers in adults: a systematic review and dose-response meta-analysis.. Inflammopharmacology. DOIPubMed
Show 4 more references
Guedes GV, Minicucci MF, Tanni SE (2022). The supplementation of L-carnitine in septic shock patients: Systematic review and meta-analysis.. Clinics (Sao Paulo, Brazil). DOIPubMed
Mohd Shukri MF, Norhayati MN, Badrin S, Abdul Kadir A (2022). Effects of L-carnitine supplementation for women with polycystic ovary syndrome: a systematic review and meta-analysis.. PeerJ. DOIPubMed
Wei G, Zhou Z, Cui Y, Huang Y, et al. (2021). A Meta-Analysis of the Efficacy of L-Carnitine/L-Acetyl-Carnitine or N-Acetyl-Cysteine in Men With Idiopathic Asthenozoospermia.. American journal of men's health. DOIPubMed
Weng Y, Zhang S, Huang W, Xie X, et al. (2021). Efficacy of L-Carnitine for Dilated Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.. BioMed research international. DOIPubMed
